Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2025-12-25 @ 12:04 AM
NCT ID:
NCT02863458
Eligibility Criteria:
Inclusion Criteria:
* patients with myeloid malignancies diagnosed during 2001-2011 at the age of 66 years or older
* alive in September 2004 (i.e. 3 months after FDA approval of azacitidine for MDS)
* known month of diagnosis, and not identified from death certificates or autopsy only
* continuous Medicare Part A and B coverage, and were not enrolled in a health maintenance organization during the period of interest
Exclusion Criteria:
* Anyone under 66 years
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
66 Years
Study:
NCT02863458
Study Brief:
Protocol Section:
NCT02863458